PRNewsWire
24 Sept 2026, 13:38 UTC · 2h ago
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Verdict
Headline leans bearish. We score SPRY −1.00 across three claims.
Score confirms the headline.
- Headline says
Leans bearish
From its wording — no explicit rating
- Expected · SPRY
−1.00strongly bearish




